NCT02852239View on ClinicalTrials.gov

Pharmacokinetics of Dabrafenib in Subjects With Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

December 19, 2016

Primary Completion Date

September 27, 2019

Study Completion Date

September 27, 2019

Conditions
Renal Impairment
Interventions
DRUG

dabrafenib

Single dose dabrafenib 100 mg

Trial Locations (3)

27612

Wake Research Associates Oncology, Raleigh

32713

Omega Research Consultants LLC, DeBary

08009

Hassman Research Institute, Berlin

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY